SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,954,604 | -24.4% | 2,868,762 | +1.4% | 0.00% | – |
Q2 2023 | $13,159,072 | +2.6% | 2,829,908 | +1.9% | 0.00% | – |
Q1 2023 | $12,829,564 | -40.0% | 2,776,962 | +5.0% | 0.00% | -100.0% |
Q4 2022 | $21,368,950 | +87.8% | 2,644,672 | +29.0% | 0.00% | – |
Q3 2022 | $11,379,000 | +7.2% | 2,050,276 | +0.6% | 0.00% | – |
Q2 2022 | $10,614,000 | -42.1% | 2,037,325 | -8.7% | 0.00% | – |
Q1 2022 | $18,338,000 | -41.8% | 2,230,997 | +5.3% | 0.00% | -100.0% |
Q4 2021 | $31,513,000 | -21.1% | 2,117,807 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $39,952,000 | +4.2% | 2,115,031 | +2.5% | 0.00% | 0.0% |
Q2 2021 | $38,355,000 | -17.4% | 2,063,195 | +1.1% | 0.00% | 0.0% |
Q1 2021 | $46,431,000 | +11.2% | 2,039,989 | +6.0% | 0.00% | 0.0% |
Q4 2020 | $41,761,000 | +219.7% | 1,923,619 | +48.0% | 0.00% | – |
Q3 2020 | $13,064,000 | +68.5% | 1,299,805 | +30.1% | 0.00% | – |
Q2 2020 | $7,753,000 | +101.0% | 998,965 | +164.2% | 0.00% | – |
Q1 2020 | $3,857,000 | +3.0% | 378,178 | +11.0% | 0.00% | – |
Q4 2019 | $3,746,000 | +27.5% | 340,587 | +5.3% | 0.00% | – |
Q3 2019 | $2,939,000 | +32.3% | 323,299 | +65.6% | 0.00% | – |
Q2 2019 | $2,222,000 | +10.4% | 195,254 | +10.5% | 0.00% | – |
Q1 2019 | $2,013,000 | +79.6% | 176,772 | +42.2% | 0.00% | – |
Q4 2018 | $1,121,000 | – | 124,283 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |